Skip to main content
Watch Insiders
TNGXHealthcare

Tango Therapeutics Inc (TNGX) Insider Trading

In the last 90 days, 2 Tango Therapeutics Inc (TNGX) insiders reported no open-market purchases and 4 sales totaling $2,198,835. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Adam CrystalPresident, R&DSale27,000$24.47$660,795
Sep 22, 2026Jessica NewcombPrincipal Accounting OfficerSale8,200$24.22$198,613
Sep 1, 2026Adam CrystalPresident, R&DSale27,000$22.37$603,909
Aug 3, 2026Adam CrystalPresident, R&DSale27,000$27.24$735,518
Jul 1, 2026Adam CrystalPresident, R&DSale27,000$29.59$798,908
Jun 1, 2026Adam CrystalPresident, R&DSale27,000$22.87$617,571
May 1, 2026Adam CrystalPresident, R&DSale27,000$21.23$573,097
Apr 15, 2026Adam CrystalPresident, R&DSale38,460$25.00$961,500

Common questions

TNGX insider trading FAQ

Are TNGX insiders buying or selling?
Over the last 90 days, TNGX insiders were net sellers, reporting $0.00 of open-market purchases and $2,198,835 of sales.
When was the last TNGX insider purchase?
No open-market insider purchase of Tango Therapeutics Inc stock was reported in the last 90 days.
Where does TNGX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Tango Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.